Relation Between Stress-Induced Myocardial Perfusion Defects on Cardiovascular Magnetic Resonance and Coronary Microvascular Dysfunction in Patients With Cardiac Syndrome X  by Lanza, Gaetano A. et al.
I
s
c
c
t
F
d
a
Journal of the American College of Cardiology Vol. 51, No. 4, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
PCardiac Imaging
Relation Between Stress-Induced
Myocardial Perfusion Defects on Cardiovascular
Magnetic Resonance and Coronary Microvascular
Dysfunction in Patients With Cardiac Syndrome X
Gaetano A. Lanza, MD,* Antonino Buffon, MD,* Alfonso Sestito, MD,* Luigi Natale, MD,†
Gregory A. Sgueglia, MD,* Leda Galiuto, MD, FACC,* Fabio Infusino, MD,* Luca Mariani, MD,*
Antonio Centola, MD,* Filippo Crea, MD, FACC*
Rome, Italy
Objectives: The purpose of this study was to investigate whether a direct relation can be demonstrated between myocardial
perfusion defects detected during dobutamine stress test (DST) by cardiovascular magnetic resonance (CMR)
and impairment of coronary microvascular dilatory function in patients with cardiac syndrome X (CSX).
Background: Despite the fact that coronary microvascular dysfunction has been shown in most patients with CSX, the isch-
emic origin of CSX remains debated. No previous study assessed whether a strict relation exists between abnor-
malities in myocardial perfusion and coronary microvascular dysfunction in CSX patients.
Methods: Eighteen CSX patients (mean age 58  7 years, 7 men) and 10 healthy control subjects (mean age 54  8
years, 4 men) underwent myocardial perfusion study by gadolinium-enhanced CMR at rest and at peak DST
(maximal dose 40 g/kg/min). Coronary flow response (CFR) to adenosine (140 g/kg/min in 90 s) in the left
anterior descending (LAD) coronary artery was assessed by high-resolution transthoracic echo-Doppler and ex-
pressed as the ratio between coronary flow velocity at peak adenosine and at rest.
Results: At peak DST, reversible perfusion defects on CMR were found in 10 CSX patients (56%) but in none of the con-
trol subjects (p  0.004). The CFR to adenosine in the LAD coronary artery was lower in CSX patients than in
control subjects (2.03  0.63 vs. 3.29  1.0, p  0.0004). The CSX patients with DST-induced myocardial per-
fusion defects in the LAD territory on CMR had a lower CFR to adenosine compared with those without perfusion de-
fects in the LAD territory (1.69 0.5 vs. 2.31  0.6, p  0.01). A significant correlation was found in CSX patients
between CFR to adenosine and a DST perfusion defect score on CMR in the LAD territory (r 0.45, p  0.019).
Conclusions: Our data concurrently show DST-induced myocardial perfusion defects on CMR and reduced CFR in the LAD cor-
onary artery territory in CSX patients, thus giving strong evidence that a dysfunction of coronary microcirculation
resulting in myocardial perfusion abnormalities is present in these patients. (J Am Coll Cardiol 2008;51:
466–72) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.060r
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(n patients with cardiac syndrome X (CSX), typical ST-
egment depression on the electrocardiogram during exer-
ise stress test suggests myocardial ischemia caused by
oronary microvascular dysfunction (1).
See page 473
The presence of coronary microvascular abnormalities in
hese patients has been supported by the detection of
rom the *Istituto di Cardiologia and the †Istituto di Radiologia, Università Cattolica
el Sacro Cuore, Rome, Italy.t
Manuscript received May 3, 2007; revised manuscript received July 9, 2007,
ccepted August 8, 2007.eversible myocardial perfusion defects during stress myo-
ardial scintigraphy (2,3) and, even more, by the evidence of
n impaired response to vasodilator stimuli of coronary
lood flow and/or resistance, assessed with several different
ethods (4–10). In particular, a blunted increase in suben-
ocardial flow in response to intravenous administration of
denosine (11) was shown by cardiovascular magnetic res-
nance (CMR), a high-resolution technique that allows the
ssessment of transmural myocardial perfusion homogeneity
ith gadolinium as contrast medium (12).
Yet, the ischemic origin of CSX remains still debated
13), mainly because of the usual lack—during stress
ests—of regional myocardial wall motion abnormalities,
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January 29, 2008:466–72 CMR and Microvascular Dysfunction in Syndrome Xhich are considered the most reliable finding of myocardial
schemia (14,15). Furthermore, some studies failed to con-
rm the impaired response to vasodilator stimuli of coronary
icrocirculation (16,17). A recent study in particular, in
ontrast with a previous one (11), did not find any apparent
mpairment of subendocardial blood flow in response to
denosine on gadolinium CMR imaging (18).
Together with these challenging data, doubts about the
icrovascular origin of CSX can also be fostered by the fact
hat in previous studies the documentation of coronary
lood flow alterations was always obtained with single
iagnostic techniques and without any clear demonstration
f a relationship between abnormalities in coronary blood
ow regulation in a myocardial region and inducibility of
ndings compatible with myocardial ischemia in the same
erritory. Also, no previous study in CSX patients assessed
hether abnormalities in coronary blood flow, attributable
o microvascular dysfunction, could be detected concor-
antly by different, independent methods in the same
atients, which would give considerable strength to the
otion of a coronary microvascular origin of the syndrome.
Accordingly, in this study we investigated, in a group of
SX patients, whether a direct relation could be demonstrated
etween the induction of myocardial perfusion defects on
adolinium CMR images during dobutamine stress test (DST)
nd the presence of abnormalities in coronary microvascular
asodilator function, as assessed by the response to adenosine
f coronary blood flow with an independent method (i.e.,
ransthoracic echocardiographic Doppler recording of the left
nterior descending [LAD] coronary artery).
ethods
ubjects. We enrolled 19 CSX patients. However, a 60-
ear-old male patient did not complete the CMR study (see
ollowing text) owing to severe chest pain during DST,
ssociated with peaking of T waves and mild ST-segment
epression in precordial leads, which required intravenous
etoprolol administration and precluded assessment of
yocardial perfusion at peak DST.
Thus, 18 patients (mean age 58 7 years, 7 men) formed
he CSX study group. All patients had a history of effort
ngina, ST-segment depression associated with angina dur-
ng at least 1 previous exercise stress test, and angiographi-
ally normal epicardial coronary arteries. Mild hypertension
as present in 6 patients, but left ventricular hypertrophy
as excluded by echocardiography in all of them. Other
ardiac or systemic diseases were carefully excluded accord-
ng to clinical history, physical examination, routine labo-
atory tests, and 2-dimensional Doppler echocardiography.
A group of 10 volunteers (mean age 54 8 years, 4 men)
erved as control subjects. These subjects were enrolled from
he non-medical staff of our hospital and were selected to be
omparable to CSX patients as to age and gender. Control
ubjects did not have any cardiac symptom or clinically relevant
isease, and they all had normal standard 12-lead electrocar- iiography (ECG), exercise stress
est, and 2-dimensional Doppler
chocardiography.
All cardiologic drugs were
ithdrawn for 72 h before the
tudy protocol. The study com-
lies with the Declaration of
elsinki and was approved by
he institutional review board of
he Università Cattolica del
acro Cuore. All subjects en-
olled gave their informed con-
ent for participation in the study.
ST. All patients and control subjects underwent DST at
east 45 min after a basal CMR study (see the following text).
ntravenous infusion of dobutamine was started at a dose of 5
g/kg/min and was increased after 5 min to 10 mg/kg/min; it
as then increased thereafter at 3-min intervals to 20, 30, and
0 mg/kg/min, if tolerated. If heart rate did not reach 85% of
ts maximal theoretical value, intravenous atropine 0.5 mg was
dministrated and repeated after 5 min, if necessary. Standard
2-lead ECG was continuously monitored throughout the
est. Furthermore, ECG was printed and blood pressure
ecorded at baseline and at the end of each DST stage until the
atient was brought to the CMR room for image acquisition.
he ECG and blood pressure were recorded as soon as
ossible after CMR recording. The occurrence of angina,
T-segment depression, or any other clinically significant
bnormality was recorded.
Dobutamine infusion was stopped in cases of intolerable
ngina, hypertensive response (blood pressure 240/140 mm
g), complex ventricular arrhythmias, or any other potentially
angerous clinical condition. The ST-segment changes did not
onstitute a criterion to stop dobutamine infusion.
MR. All participants underwent gadolinium-enhanced
MR study at rest and at peak DST. The stress study was
erformed at least 45 min after the rest study, to permit
learance of gadolinium after the first injection.
The CMR was performed with a 1.5-T scanner (Signa
xcite2, General Electrics Medical Systems, Buc, Paris,
rance), with a cardiac 8-channel phased array dedicated
eceiver coil and following a standardized protocol (19). All
equences were obtained with ECG-gating and during
reath-holding by the patient.
After a tri-plane localizer, vertical long-axis (2-chamber
iew) and horizontal long-axis (4-chamber view) steady
tate free precession (FIESTA) sequences were acquired.
he scan parameters for long-axis cine sequences were:
epetition time/echo time/flip angle (TR/TE/FA) 4.0 ms/
.4 ms/45°, slice thickness 8 mm, matrix 224  288,
umber of excitations (NEX) 1, bandwidth 125 kHz.
Contrast medium (gadolinium-DTPA, Magnevist
chering AG, Berlin, Germany) was injected through a
4-gauge cannula in an antecubital vein, at a dose of 0.1
mol/kg, with a flow rate of 3 to 4 ml/s. Perfusion first-pass
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
CSX  cardiac syndrome X
DST  dobutamine stress
test
ECG  electrocardiography
LAD  left anterior
descendingmaging was obtained through 3 short-axis views (basal,
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CMR and Microvascular Dysfunction in Syndrome X January 29, 2008:466–72id-ventricular, and apical), with a fast gradient echo train
equence. Different frames of the chosen planes were
cquired during 1 min. Owing to this long acquisition time,
atients were instructed to hold their breath at end-
xpiration as long as possible and then to breath superficially
nd slowly thereafter. The scan parameters for first-pass
maging were: TR/TE/FA 6.9 ms/1.6 ms/25°, slice thick-
ess 8 mm, gap 12 to 15 mm, matrix 128  128, NEX 1,
andwidth 125 kHz.
After first-pass imaging, global systolic function assess-
ent was obtained employing a modified short-axis very
ast FIESTA sequence (FIESTA-SP), encompassing the
hole left ventricle. Total scan time was approximately 30 s,
ivided in 2 to 3 breath-holds. The scan parameters for this
mage acquisition were: TR/TE/FA 3.2 ms/1.3 ms/45°,
lice thickness 8 mm, gap 0 mm, matrix 192  184, NEX
.5, bandwidth 125 kHz.
The same study protocol was applied at rest and at peak
obutamine infusion. Approximately 15 min after stress
maging, delayed enhancement sequence was obtained in
hort-axis, with a conventional inversion recovery-fast gra-
ient echo technique in the same orientation of the 3 slices
f the first-pass study and of the functional study. Param-
ters of the sequence were: TR/TE/FA 6.6 ms/3.1 ms/20°
very heartbeat, slice thickness 8 mm, gap 0 mm, matrix 256
192, NEX 1 to 2.
The first-pass study was analyzed both in qualitative and
emi-quantitative ways, with a 16-segment left ventricle
odel. On qualitative assessment, perfusion defects were
efined as subendocardial or transmural visually dark myo-
ardial areas, respecting coronary distribution, with a delay
f at least 2 s compared with remote healthy myocardium,
nd persisting for at least 10 frames (19).
Semi-quantitative analysis was performed by signal in-
ensity (SI)/time curves, with a commercially available
oftware (Mass plus, Medis, Leiden, the Netherlands);
ndocardial and epicardial borders of the 3 slices were traced
anually, and curves and bull’s eye plots were obtained by 2
ndependent skilled operators, with divergences being re-
olved by consensus.
A score was assigned for each left ventricular segment,
ccording to the following scale: 0  no perfusion defect; 1
subendocardial perfusion defect with transmural exten-
ion 25%; 2  subendocardial perfusion defect with
ransmural extension between 25% and 50%; 3  suben-
ocardial perfusion defect with transmural extension be-
ween 50% and 75%; and 4  subendocardial perfusion
efect with transmural extension 75%.
For each patient a total score was obtained as the sum of
he individual scores of each segment. If a perfusion defect
as also present at rest, the stress-related (ischemic) score
as calculated as the difference between the score after stress
inus the score at rest.
oronary flow response to adenosine. The tests were all
erformed in the morning by the same expert echocardiog- Sapher within  2 days of CMR study, following a
ell-standardized protocol (20). Subjects were positioned in
he left lateral decubitus position in a quiet, temperature-
ontrolled room (22°C). The LAD coronary artery was
maged by a 7-MHz transducer connected to an Acuson
equoia C512 ultrasound system (Siemens S.p.A., Milano,
taly), and flow in its mid-distal portion of the vessel was
nterrogated with color Doppler mapping. Color gain was
djusted to provide optimal images. A 2-mm-wide sample
olume was then positioned on the color signal of the LAD
oronary artery, and when an anterograde monophasic
ecrescendo diastolic flow was confirmed, Doppler spectral
racing of LAD coronary flow velocity was recorded.
Coronary microcirculatory dilation and consequent in-
rease in coronary blood flow velocity was induced by
nfusion of adenosine (140 g/kg/min in 90 s) under
onstant ECG and blood pressure monitoring. Peak coro-
ary blood flow velocity was measured at baseline and
uring adenosine infusion. For each phase, the 3 highest
oppler velocities were averaged. The CFR to adenosine
as expressed as the ratio of hyperemic to basal peak
iastolic coronary blood flow velocity.
tatistics. Continuous variables showed a normal distribu-
ion according to the Kolmogorov-Smirnov test and were
ompared by the Student t test. Covariance analysis was
pplied to adjust average differences for potentially con-
ounding variables. Bonferroni’s rule for 2 comparisons was
pplied to compare CFR to adenosine in the subgroups of
SX patients with and without DST-induced reversible
erfusion defects on gadolinium CMR imaging in the LAD
rtery territory with CFR to adenosine in healthy control
ubjects. Proportions were compared by the Fisher exact
est. Correlation analyses were performed by the Spearman
ank test.
Data are reported as mean  SD. A 2-sided p value
0.05 was always required for statistical significance. The
oftware SPSS version 12.0.2 (SPSS Inc., Florence, Italy)
as used for statistical analyses.
esults
linical data. The main clinical characteristics of CSX
atients and healthy subjects who completed the study are
ummarized in Table 1. Overall, CSX patients tended to
ave more cardiovascular risk factors and were taking more
edications, although differences did not achieve statistical
ignificance.
MR study. The main DST results are summarized in
able 2. Heart rate and blood pressure at rest and at peak
ST did not differ between CSX patients and control
ubjects. Angina was induced by DST in 9 CSX patients
50%) and in none of the control subjects (p  0.01).
T-segment depression also occurred in 9 CSX patients but
n no healthy control subjects (p  0.01). Both angina and
T-segment depression occurred in 7 patients. No left
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January 29, 2008:466–72 CMR and Microvascular Dysfunction in Syndrome Xentricular wall motion abnormalities were detected on
MR during DST.
No perfusion defects during gadolinium-enhanced first-
ass CMR were found at rest in any of the CSX patients
nd control subjects. In contrast, at peak DST, perfusion
efects were found in 10 CSX patients (56%, Fig. 1) but in
one of the control subjects (p  0.004).
The perfusion defects were limited to 1, 2, 3, and 4
egments in 3, 3, 3, and 1 CSX patients, respectively. In 6
atients the perfusion defect was limited to the subendo-
ardial layer (transmural myocardial perfusion 25% of
yocardial thickness), whereas in 4 patients the perfusion
efect extended between 25% and 50% of myocardial
hickness in 1 or more myocardial segment. In 8 of 10 CSX
atients, myocardial perfusion defects were localized in the
ain Clinical Characteristicsf Subjects Enrolled in the Study
Table 1 Main Clinical Characteristicsof Subjects Enrolled in the Study
CSX Patients
(n  18)
Control Subjects
(n  10)
p
Value
Age (yrs) 58 7 55 8 0.24
Gender (M/F) 7/11 4/6 1.00
Cardiovascular risk factors,
n (%)
Family history of CAD 9 (50%) 5 (50%) 1.00
Hypertension 11 (61%) 3 (30%) 0.24
Hypercholesterolemia 10 (56%) 2 (20%) 0.11
Smoking 2 (11%) 0 0.52
Drug therapy, n (%)
Beta-blockers 8 (44%) 1 (10%) 0.10
Calcium-channel blockers 4 (22%) 2 (20%) 1.00
Nitrates 4 (22%) 0 0.26
ACE inhibitors 9 (50%) 3 (30%) 0.43
Diuretics 3 (17%) 0 0.53
Statins 6 (33%) 1 (10%) 0.36
Aspirin 10 (56%) 2 (20%) 0.11
CE angiotensin-converting enzyme; CAD coronary artery disease; CSX cardiac syndrome X.
emodynamic Parameters of Subjectsuring Coronary Dobutamine tress Test
Table 2 Hemodynamic Parameters of SubjectsDuring Coronary Dobutamine Stress Test
CSX Patients
(n  18)
Control
Subjects
(n  10)
p
Value
Basal
Heart rate (beats/min) 63 11 64 8 0.74
Systolic blood pressure
(mm Hg)
133 10 132 12 0.81
Rate–pressure product
(beats/min  mm Hg)
8,408 1,677 8,566 1,630 0.81
Peak dobutamine
Heart rate (beats/min) 127 16 136 8 0.11
Systolic blood pressure
(mm Hg)
171 18 158 26 0.15
Rate–pressure product
(beats/min  mm Hg)
21,694 3,532 21,465 3,145 0.87
ST-segment depression
1 mm
9 (50%) 0 0.01
Angina 9 (50%) 0 0.01SX  cardiac syndrome X. CAD coronary artery territory, whereas in 2 patients they
ere shown in the right coronary artery territory.
Angina during DST was referred by 6 (60%) and by 3
37%) of CSX patients with and without perfusion defects
n CMR, respectively (p  0.64). Also, ST-segment depres-
ion during DST was observed in 6 and 3 CSX patients with
r without perfusion defects on CMR, respectively (p 0.64).
oronary flow response to adenosine. No relevant side
ffects were observed during intravenous adenosine infusion,
lthough some patients experienced transient minor side
ffects, including dyspnea and headache. Heart rate and
lood pressure were similar, both at rest and at peak
denosine, in the 2 groups (Table 3). Among CSX patients,
Figure 1 Coronary Flow Response to
Adenosine in CSX Patients and Control Subjects
Individual and average (SD) values of coronary blood flow response to
adenosine in the left anterior descending (LAD) coronary artery, as
assessed by transthoracic echo-Doppler, in cardiac syndrome X (CSX)
patients and in healthy control subjects. The CSX patients are divided into
those showing reversible perfusion defects (CSX LAD/CMR) and those not
showing any reversible regional perfusion defects (CSX LAD/CMR) in the
LAD territory on cardiovascular magnetic resonance (CMR) during dobut-
amine stress test.
emodynamic Parameters ofubjects During Coronary Flow Reserve Study
Table 3 Hemodynamic Parameters ofSubjects During Coronary Flow Reserve Study
CSX Patients
(n  18)
Control Subjects
(n  10)
p
Value
Basal
Heart rate (beats/min) 63 9 69 12 0.13
Systolic blood pressure
(mm Hg)
129 10 125 10 0.26
Rate–pressure product
(beats/min  mm Hg)
8,153 1,252 8,723 1,764 0.33
Peak adenosine
Heart rate (beats/min) 72 14 84 17 0.08
Systolic blood pressure
(mm Hg)
130 17 125 12 0.39
Rate–pressure product
(beats/min  mm Hg)
9,429 2,135 10,225 1,820 0.33
ST-segment depression
1 mm
6 (33%) 0 (0%) 0.12
Angina 5 (28%) 0 (0%) 0.28SX  cardiac syndrome X.
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CMR and Microvascular Dysfunction in Syndrome X January 29, 2008:466–72(27.8%) developed anginal pain and 6 (33%) developed
T-segment depression. No healthy control subjects devel-
ped either angina or ST-segment changes during adeno-
ine infusion.
In CSX patients, compared with control subjects, LAD
oronary blood flow velocity tended to be higher at rest
226.8  94 cm/s vs. 179.2  46 cm/s, p  0.25) but lower
t peak adenosine (452.5  170 cm/s vs. 576.3  85 cm/s,
 0.11). As a result, CFR to adenosine was significantly
ower in CSX patients than in control subjects (2.03  0.6
s. 3.29  1.0, p  0.0004). The difference in CFR to
denosine in the LAD coronary artery between the 2 groups
ersisted unchanged after adjustment for basal LAD coro-
ary flow velocity (p  0.01).
The CSX patients with a perfusion defect in at least 1
yocardial segment in the LAD coronary artery territory
n DST-CMR had a significantly lower CFR to adeno-
ine in the LAD artery compared with those with no
ST-induced myocardial perfusion defects in the LAD
oronary artery territory on CMR (1.69  0.5 vs. 2.31 
.6, p  0.037).
The latter group, however, still showed a significantly
ower CFR to adenosine in the LAD artery compared with
ontrol subjects (p  0.05) (Fig. 2).
Interestingly, in the 2 patients with DST-induced perfu-
ion defects in the right coronary artery territory, CFR to
denosine in the LAD artery was clearly reduced in 1 (1.6)
nd at the bottom of the range of values of healthy control
ubjects (2.1) in the other patient, thus suggesting a more
eneralized microvascular dysfunction. Notably, CFR to
denosine in the LAD artery was still lower in the 8 CSX
atients without any appreciable reversible perfusion defects
Figure 2 Myocardial Perfusion Defect on CMR During DST in a
Cardiovascular perfusion magnetic resonance (CMR) first-pass study in a patient w
administration of gadolinium at peak dobutamine stress test (DST), a perfusion de
malizes at rest (right).n CMR images, as compared with control subjects (2.42
.6 vs. 3.29  1.0, p  0.05).
A significant correlation was found in CSX patients
etween CFR to adenosine in the LAD artery and CMR
erfusion defect score during DST in the LAD territory (r
0.45, p  0.019).
iscussion
n this study, for the first time, we give evidence in CSX
atients of a strict relation between impairment of coronary
icrovascular vasodilation in the LAD coronary artery (as
ssessed by CFR to adenosine) and induction of reversible
erfusion defects by DST on CMR images in the same
yocardial territory. The concordance between these ab-
ormal findings, obtained by independent operators with 2
ndependent techniques and methods, lend strong support
o the notion that coronary microvascular dysfunction is a
ajor cause of CSX.
icrovascular dysfunction in CSX. Although suggested
ince the early descriptions of the syndrome, the coronary
icrovascular origin of syndrome X has long been debated.
The ST-segment depression during stress-induced an-
ina is a landmark of CSX and suggests myocardial ischemia
aused by microvascular dysfunction (1), which is also
uggested by reversible perfusion defects detectable by stress
yocardial scintigraphy in several patients (2,3). More
irect evidence of a coronary microvascular dysfunction
omes from studies showing an impaired response of coro-
ary blood flow/resistance to primarily endothelium-
ndependent stimuli, including dipyridamole, adenosine,
nd papaverine, with several different diagnostic techniques
thermodilution, intracoronary Doppler recording, positron
nt With CSX
rdiac syndrome X (CSX) (short-axis plane). In the left panels, obtained 26 s after
clearly visible in the mid-ventricular septum (arrows). The perfusion defect nor-Patie
ith ca
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January 29, 2008:466–72 CMR and Microvascular Dysfunction in Syndrome Xmission tomography, CMR) (4–11). Furthermore, an
mpairment of endothelium-dependent coronary microvas-
ular dilation has been shown by several studies (6–8), and
ther data also support an increased vasoconstrictor reactiv-
ty of small coronary artery vessels in these patients (5,21).
Despite this evidence, some authors have questioned the
icrovascular/ischemic origin of CSX, objecting that the
emonstration of myocardial ischemia would require the
vidence of more specific and convincing alterations, includ-
ng typical metabolic changes and left ventricular wall
otion abnormalities (14,15). In fact, some studies failed to
nd stress-induced metabolic abnormalities (22) or left
entricular dysfunction indicative of myocardial ischemia
3,23). Yet, a metabolic evidence of stress-induced myocar-
ial ischemia, including myocardial lactate production (24),
oronary sinus oxygen desaturation (25), and myocardial
hosphorus-31 metabolism by CMR spectroscopy (26), has
een obtained in at least a subgroup of CSX patients.
urthermore, Buffon et al. (27), in a group of these patients,
ound a high myocardial release of lipoperoxide products in
he coronary circulation after atrial pacing, similar to that
ound in patients after coronary occlusion by balloon infla-
ion during percutaneous coronary intervention.
In a previous study, Panting et al. (11), with gadolinium
MR imaging, supported the presence of coronary micro-
ascular dysfunction in CSX patients by showing an impair-
ent of myocardial perfusion in subendocardial layers in
esponse to adenosine. This finding has recently been
hallenged by Vermeltfoort et al. (18), who with an analo-
ous protocol found a similar, apparently normal, increase in
ubendocardial and subepicardial blood flow in response to
denosine in a group of patients with angina and normal
oronary arteries, although 2 patients (10%) showed revers-
ble perfusion defects. The population of this study, how-
ver, seems quite heterogeneous and no control group was
ncluded (18).
In the present study, we provide novel evidence of
oronary microvascular dysfunction in CSX patients. In-
eed, with dobutamine as a pharmacological stressor, we
howed reversible perfusion defects on CMR images in
ore than one-half of patients but in none of the healthy
ontrol subjects. Perfusion defects were localized in suben-
ocardial layers, in keeping with the findings of Panting et
l. (11). Most important, in our study we found a strict
elation between the DST-induced reversible perfusion
efects on CMR and the reduced CFR to adenosine, as
ssessed by transthoracic Doppler coronary flow recording,
n the LAD territory, thus confirming by an independent
ethod the microvascular origin of the CMR perfusion
efects. Most regional perfusion defects were observed in
he LAD territory, but they were detectable in the right
oronary artery territory in 2 patients, thus suggesting the
mportance of the assessment of the whole coronary circu-
ation in these patients.
Perfusion defects and reduced CFR to adenosine were
ot associated with left ventricular wall motion abnormali- fies, which could be explained with a patchy distribution of
icrovascular dysfunction and/or with a limited extension
nd severity of ischemia (28).
Also, only a minority (27.8%) of our patients developed
ngina pain during adenosine infusion, in contrast with the
5% rate of chest pain reported by CSX patients in
anting’s study (11). The reasons for this difference are not
ompletely clear, but it might be explained, at least in part,
y the shorter duration of adenosine infusion in our study
1.5 min vs. 6 min) and by the possible inclusion of a
ifferent proportion of patients with increased painful per-
eption of cardiac stimuli, a distinctive finding that can be
resent and contribute to the symptomatic burden in a
ariable number of CSX patients (29,30).
Interestingly, our data suggest that coronary microvascu-
ar dysfunction in most CSX patients can be more diffuse
han that indicated by the evidence of reversible regional
erfusion defects on stress CMR and can also be present in
atients who do not exhibit reversible perfusion defects at
ll. Indeed, CFR to adenosine in the LAD coronary artery
eemed low in the 2 patients who displayed reversible
erfusion defects only in the right coronary artery territory
nd was also reduced, on average, compared with healthy
ontrol subjects, in the group of CSX patients in whom no
pparent regional perfusion defects could be detected. A
atchy diffused form of mild coronary microvascular dys-
unction, not sufficiently confluent to result in detectable
egional perfusion defects (27), might be involved in these
ases, in agreement with our recent data showing diffuse
eduction of CFR to adenosine in a group of CSX patients
n contrast echocardiography (31).
However, in the few patients showing both adequate
FR to adenosine and normal CMR imaging on DST,
hest pain episodes might be caused by mechanisms differ-
nt from coronary microvascular dysfunction, including
ure enhanced cardiac pain sensitivity (29,30), or even
oncardiac causes. Yet, it cannot be excluded that, at least in
ome patients, the lack of demonstration of coronary mi-
rovascular alterations in our study might have been related
o variability over time of the mechanisms responsible for the
oronary microvascular dysfunction or to inadequacy of stress
timuli used to reveal coronary microvascular abnormalities.
onclusions
ur data show a correlation between myocardial perfusion
bnormalities on CMR during pharmacological stress test
nd reduced coronary microvascular vasodilator response to
denosine in patients with CSX. The concordance between
hese abnormal findings, obtained by independent methods,
trongly supports the notion that coronary microvascular dys-
unction is a key pathogenetic component of this syndrome.
These findings also suggest that transthoracic echo-
oppler study of the LAD coronary artery could represent
useful screening modality to assess coronary microvascularunction in patients with chest pain and normal coronary
a
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ethod for a complete characterization of coronary micro-
irculatory dysfunction in CSX patients.
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